Market Overview

Benzinga's Top Initiations

Benzinga's Top Initiations
Related LJPC
La Jolla Pharmaceutical Company Receives Positive Opinion from European Orphan Committee for LJPC-401
Stocks Hitting 52-Week Highs
Related DRII
Little Passports Enters Agreement with Diamond Resorts International
Barron's Recap: Why Alibaba Could Plunge Another 50%

Analysts at Jefferies initiated coverage on La Jolla Pharma (NASDAQ: LJPC) with a Buy rating. The target price for La Jolla Pharma is set to $25. La Jolla Pharma's shares closed at $9.40 on Friday.

Imperial Capital initiated coverage on shares of Diamond Resorts (NYSE: DRII) with a Outperform rating. The target price for Diamond Resorts is set to $34. Diamond Resorts' shares closed at $24.95 on Friday.

Latest Ratings for LJPC

Apr 2015OppenheimerInitiates Coverage onOutperform
Mar 2015Chardan CapitalReinstatesBuy
Aug 2014JefferiesInitiates Coverage onBuy

View More Analyst Ratings for LJPC
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings


Related Articles (LJPC + DRII)

View Comments and Join the Discussion!

Get Benzinga's Newsletters